GlassScriptPhysician profile
Kalpesh Patel
NPI 1053572263
$11,733.22
in general payments reported to CMS, 2019-2025
42 companies · $629 in 2025
The $629 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $733 · 2021: $1,026 · 2022: $838 · 2023: $6,112 · 2024: $1,728 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,089 · Education: $3,000 · Travel and Lodging: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,088.88 |
| Education | $3,000.00 |
| Travel and Lodging | $1,380.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,396.33 | 2023 | Ion, Da Vinci Surgical System |
| Abbott Laboratories | $1,152.16 | 2019-2025 | Gallant, Aveir, Dragonfly Opstar |
| Novartis Pharmaceuticals Corporation | $857.51 | 2019-2025 | |
| Amgen INC. | $808.88 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $423.52 | 2023-2025 | Lux-Dx Insertable Cardiac Monitor, Exalt Model D, Cds - Other |
| Sanofi-Aventis U.S. LLC | $419.99 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $413.52 | 2022-2025 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $379.54 | 2019-2024 | Lifevest |
| Sumitomo Pharma America, INC. | $286.30 | 2023-2024 | Orgovyx, Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $247.77 | 2019-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $246.98 | 2020-2022 | |
| Medtronic, INC. | $207.68 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Micra, Corevalve Evolut R |
| Conmed Corporation | $203.96 | 2020 | |
| Pfizer INC. | $188.46 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $168.07 | 2021-2024 | Verquvo |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $145.74 | 2020-2024 | Xarelto |
| Cvrx, INC. | $107.55 | 2023-2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $101.34 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $93.91 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.18 | 2021-2023 | Jardiance |
| Novo Nordisk INC | $82.08 | 2021-2025 | Ozempic |
| Heartflow, INC. | $71.05 | 2023-2025 | Ffrct |
| Shockwave Medical, INC | $67.22 | 2021-2025 | |
| Abiomed | $65.68 | 2024-2025 | Impella |
| Edwards Lifesciences Corporation | $64.20 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Esperion Therapeutics, INC. | $54.26 | 2020-2024 | Nexletol |
| Bridgebio Pharma, INC. | $47.96 | 2025 | Attruby |
| Cardiovascular Systems INC. | $47.17 | 2019-2020 | |
| Itamar Medical INC | $37.47 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $35.76 | 2024 | Arcalyst |
| Ge Healthcare | $31.66 | 2021 | |
| Digirad Health, INC | $29.98 | 2024 | Digirad Cardius |
| Ambu INC. | $27.27 | 2025 | |
| Inari Medical, INC. | $17.14 | 2022 | |
| Althera Pharmaceuticals LLC | $16.56 | 2021-2022 | |
| Inspire Medical Systems, INC. | $16.04 | 2023 | Inspire |
| Kiniksa Pharmaceuticals, LTD. | $15.68 | 2023 | Arcalyst |
| Teleflex LLC | $15.56 | 2025 | Guideliner |
| Scpharmaceuticals INC. | $14.98 | 2023 | |
| Baxter Healthcare | $14.24 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Tactile Systems Technology INC | $13.01 | 2021 | |
| G Medical Diagnostic Services, INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalpesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.